Physician profile
Eric M Persily
NPI 1376543405
$533.70
in general payments reported to CMS, 2019-2025
10 companies · $216 in 2025
The $216 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.29 · 2021: $30.00 · 2022: $66.78 · 2023: $57.89 · 2024: $145 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $292.41 | 2023-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.97 | 2022-2025 | Xifaxan |
| Eagle Pharmaceuticals, INC. | $40.58 | 2023 | |
| Alcon Vision LLC | $35.63 | 2022 | |
| Mallinckrodt Hospital Products INC. | $30.60 | 2024 | Terlivaz |
| Acacia Pharma INC | $28.40 | 2021-2022 | |
| Ivantis, INC | $18.29 | 2020 | |
| Lilly USA, LLC | $16.72 | 2025 | Omvoh |
| Johnson & Johnson Surgical Vision, INC. | $15.92 | 2021 | |
| Novo Nordisk INC | $14.18 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Persily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.